Gatekeepers or intermediaries? The role of clinicians in commercial genomic testing.
Many commentators on "direct-to-consumer" genetic risk information have raised concerns that giving results to individuals with insufficient knowledge and training in genomics may harm consumers, the health care system, and society. In response, several commercial laboratories offering gen...
Main Authors: | Michelle L McGowan, Jennifer R Fishman, Richard A Settersten, Marcie A Lambrix, Eric T Juengst |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4178171?pdf=render |
Similar Items
-
Big data, open science and the brain: lessons learned from genomics
by: Suparna eChoudhury, et al.
Published: (2014-05-01) -
Financial Intermediaries and the Commercialization of Microfinance
by: Chun-I Lin, et al.
Published: (2012) -
Guides, not gatekeepers
by: Michael N Dawson, et al.
Published: (2014-09-01) -
Legal Regulation of Commercial Intermediary Agreements under the EU Law
by: M. A. Anosov
Published: (2010-09-01) -
Gatekeepers
by: Lenard Wells
Published: (2013-10-01)